Ruoyu Jiang

机构：Nanjing University of Chinese Medicine, China Pharmaceutical University, Tianjin Medical University General Hospital, Zhejiang University · ORCID：0000-0002-9499-1129

发表论文 59 篇 · 总被引 548 次 · h-index 13

代表论文

• The gasdermin family: emerging therapeutic targets in diseases (2024 · Signal Transduction and Targeted Therapy · 被引 106)
• Cancer-associated fibroblasts in papillary thyroid carcinoma (2023 · Clinical and Experimental Medicine · 被引 21)
• Integrated analysis of tumor microenvironment features to establish a diagnostic model for papillary thyroid cancer using bulk and single-cell RNA sequencing technology (2023 · Journal of Cancer Research and Clinical Oncology · 被引 18)
• The impact of Rituximab administered before transplantation in patients undergoing allogeneic hematopoietic stem cell transplantation: A real-world study (2022 · Frontiers in Immunology · 被引 14)
• miR-22 promotes immunosuppression via activating JAK/STAT3 signaling in cutaneous squamous cell carcinoma (2023 · Carcinogenesis · 被引 11)
• druglikeFilter 1.0: An AI powered filter for collectively measuring the drug-likeness of compounds (2025 · Journal of Pharmaceutical Analysis · 被引 8)